The Headline Numbers
The World Bank's October 8, 2014 report modelled two scenarios for West Africa as a whole. In the "Low Ebola" scenario — containment by early 2015 — lost GDP was estimated at $2.2 billion in 2014 and $1.6 billion in 2015, or $3.8 billion over two years. In the "High Ebola" scenario, with the disease spreading in force to neighbouring countries, the figures were $7.4 billion and $25.2 billion — $32.6 billion. Both scenarios assumed at least some spread beyond Guinea, Liberia and Sierra Leone (World Bank press release, October 8, 2014).
The peer-reviewed synthesis is Huber, Finelli and Stevens in the Journal of Infectious Diseases (2018). Their systematic review of published and grey-literature estimates found the lost-GDP figures ranging from $2.8 billion to $32.6 billion, and — adding six categories of social cost the GDP estimates omit — put the comprehensive economic and social burden at $53.19 billion in 2014 dollars. The largest single component, $18.8 billion, was deaths from non-Ebola causes.
Key figures at a glance — and what kind of number each one is
- $3.8 billion (2014 + 2015): World Bank "Low Ebola" scenario, West Africa — a forecast made in October 2014, not a measurement
- $32.6 billion (2014 + 2015): World Bank "High Ebola" scenario — the same forecast's upper bound, which did not materialise
- $2.8–32.6 billion: the range of all lost-GDP estimates found by Huber et al.'s systematic review (2018) — retrospective estimates and forecasts mixed
- $53.19 billion: Huber et al.'s comprehensive burden, 2014 USD — an extrapolation that values lives lost to non-Ebola causes, lost education, and other social costs; $18.8 billion of it is non-Ebola deaths
Our calculation, for scale: $53.19 billion ÷ 28,610 reported cases (CDC's count) ≈ $1.86 million per case. That is not a "cost of treating Ebola"; nearly all of it is the epidemic's effect on people who never had Ebola. It is the arithmetic behind the section that follows.
Aversion Behavior: Fear Cost More Than the Disease
The most important economic insight from the West Africa epidemic is that behavioral aversion — the economic losses driven by fear rather than by actual infection — exceeded the direct cost of the disease in the affected countries. Traders stopped crossing borders. Farmers left fields unworked. Businesses closed not because workers were sick but because customers stopped coming.
Agriculture, mining, and trade — the economic foundations of Guinea, Liberia, and Sierra Leone — were disrupted simultaneously. Crop harvests were reduced as farmers avoided communal work and market travel. Mining output, a primary export earner for all three countries, fell as foreign workers evacuated and local workforces reduced activity. Import prices rose as shipping companies imposed surcharges or rerouted vessels away from affected ports.
This "aversion multiplier" is a defining feature of high-mortality infectious diseases: the economic radius of the outbreak is far wider than the geographic radius of actual transmission. Understanding it is critical for modeling the economic risk of any future Ebola outbreak.
Beyond Direct Disease Cost: Cascading Health-System Failure
The $53.19 billion broader burden estimate (Journal of Infectious Diseases, 2018) captures something the GDP figures miss: when Ebola overwhelmed the health systems of Guinea, Liberia, and Sierra Leone, routine care for other conditions — malaria, maternal complications, tuberculosis — became inaccessible. Health workers died or fled. Clinics closed. The non-Ebola mortality from this cascading health-system failure was large enough to become a material component of the total economic and social burden.
This pattern — an acute outbreak destroying the health infrastructure needed to manage endemic disease, creating a second wave of mortality and economic loss — is now recognized as a standard risk in low-resource settings, and it shapes how international outbreak response is funded and staffed.
The 2026 Bundibugyo Outbreak: Economic Dimension
The ongoing 2026 Bundibugyo virus outbreak is centered in the Democratic Republic of the Congo (with a smaller arm in Uganda that was declared over in the summer). It has become the second-largest Ebola outbreak on record — 7,200 confirmed cases and 3,475 deaths in DRC as of September 12, 2026, per CDC, in six provinces and 61 health zones per WHO — so its economic footprint is larger than early framing suggested, even though it remains more geographically concentrated than the multi-country 2014–16 West Africa epidemic. Outbreaks in low-income, conflict-affected settings generate immediate costs through:
- Contact tracing and quarantine operations (local labor and logistics costs)
- Regional trade disruption at affected border crossings
- Tourism and hospitality impact in affected districts
- Health-worker protective equipment and surge staffing costs
An aggregate economic-burden estimate for the 2026 outbreak is not yet available from the WHO or CDC at time of writing (figures above are case data, not cost estimates), and we will not fill the gap with a number of our own. What can be sourced are the response inputs and the setting:
- US$518 million — the funding ask of the Africa CDC–WHO joint continental preparedness and response plan launched June 5, 2026, covering preparedness across African countries as well as the DRC response (WHO DON 606). It is a budget request, not a cost of the outbreak.
- More than 26 million people in DRC experiencing acute food insecurity and roughly one million internally displaced people in Ituri Province alone — WHO's description of the setting the outbreak is unfolding in (DON 617). Aversion losses land on an economy already in humanitarian crisis, which makes them harder to isolate from everything else.
- 24,719 contacts requiring daily follow-up as of September 7, 2026 (WHO DON 617), and about 500 CDC staff on the response with more than 120 deployed (CDC, September 14, 2026) — the labour-cost side of contact tracing, none of it yet priced in a public document.
What a credible 2026 estimate would need: a counterfactual GDP path for the six affected provinces (DRC publishes national, not provincial, accounts); trade data for the Uganda and South Sudan crossings where CDC notes "frequent population movement and cross-border travel"; and a method for separating Ebola's effect from the conflict and displacement already depressing output in eastern DRC. The World Bank produced its 2014 scenarios within three months of the PHEIC; as of September 14, 2026 — four months after this one — no equivalent has been published. The 2014–16 template suggests the critical variable is containment speed: every week the outbreak remains uncontained multiplies behavioral aversion costs across a wider regional economy, and CDC's September operational review described this outbreak's expansion as "uncontrolled."
Compared to what? For the economic footprint of other outbreaks the network tracks, see the hub's pandemic economic impact overview; for Ebola's health burden alongside 14 other viruses, the Virus Risk Perspective and this site's Ebola risk perspective.
For the latest outbreak updates, see the 2026 Ebola Outbreak tracker.
Sources & References
- World Bank Group. The Economic Impact of the 2014 Ebola Epidemic: Short and Medium Term Estimates for West Africa (press release, October 8, 2014). worldbank.org
- Huber C, Finelli L, Stevens W. The Economic and Social Burden of the 2014 Ebola Outbreak in West Africa. J Infect Dis 2018;218(suppl 5):S698–S704. doi:10.1093/infdis/jiy213
- Centers for Disease Control and Prevention. Ebola Outbreak: Current Situation. Page dated September 14, 2026. cdc.gov/ebola/situation-summary
- Centers for Disease Control and Prevention. History of Ebola Outbreaks (2014–16 case count). Reviewed May 29, 2026. cdc.gov/ebola/outbreaks
- Kabasele D, et al. Notes from the Field: Characteristics and Monitoring of the 2026 Outbreak — DRC, August 2026. MMWR 2026;75(35):554–556. doi:10.15585/mmwr.mm7535e1
- World Health Organization. Disease Outbreak News 606 (June 8, 2026) and 617 (September 10, 2026): Ebola disease caused by Bundibugyo virus. who.int/…/2026-DON617
